Lungemboli
Senast uppdaterad: Senast reviderad:
Sakkunnig:Peter J Svensson
Definition:
Lungemboli, LE, är en ocklusion (blodpropp) i en eller flera lungartärer, oftast som led i venös tromboembolism (emboli från DVT).
Förekomst:
Incidensen LE i Sverige är cirka 65 per 100 000 invånare och år. Incidensen ökar med stigande ålder, och är bland personer >80 år 300–400 per 100 000 invånare och år.
Symtom:
Symtombilden skiljer sig mycket och har ett brett spektrum från lätt rethosta, akut svår andnöd och till plötslig död.
Kliniska fynd:
Takypné av olika grad, eventuellt chocksymtom; gråblek och fuktig hud, svag och snabb puls och lågt blodtryck hos medtagen och orolig patient.
Diagnostik:
Kompletterande undersökningar är D-dimer, EKG, DT lungartärer eller lungskintigrafi.
Behandling:
Akutbehandling med heparin eller NOAK, eventuellt trombolys. NOAK är förstahandsval som sekundärprofylax.
- Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Heart J 2019. PMID: 31473594 PubMed
- Baksaas ST, Geiran OR, Iversen S. Kirurgi ved kronisk lungeemboli. Tidsskr Nor Lægeforen 2001; 121: 431-3. tidsskriftet.no
- Socialstyrelsen. Statistikdatabas för diagnoser i sluten vård. Lungemboli. Hämtad 2018-01-24 sdb.socialstyrelsen.se
- Douketis J, Tosetto A, Marucci M, et al. Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. BMJ 2011; 342: d813. PubMed
- Apenteng PN, Hobbs FR, Roalfe A, et al. Incidence of venous thromboembolism in care homes: a prospective cohort study. Br J Gen Pract 2017 Feb; 67 (655): e130-e137. pmid:28093420. PubMed
- Hughes MJ, Stein PD, Matta F. Silent pulmonary embolism in patients with distal deep venous thrombosis: systematic review. Thromb Res. 2014 Dec;134(6):1182-5. doi: 10.1016/j.thromres.2014.09.036. DOI
- Velmahos GC, Spaniola K, Tabbara M, et al. Pulmonary embolism and deep venous thrombosis in trauma: are they related?. Arch Surg 2009; 144: 928-32. PubMed
- Andreassen AK. Kronisk tromboembolisk pulmonal hypertensjon. Hjerteforum 2016; 29 (nr. 3): 19-25. www.legeforeningen.no
- Eichinger S, Weltermann A, Minar E, et al. Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism. Arch Intern Med 2004; 164: 92-6. PubMed
- Carrier M, Le Gal G, Wells PS, Fergusson D, Ramsay T, Rodger MA. Systematic review: The Trousseau Syndrome revisited: Should we screen extensively for cancer in patients with venous thromboembolism? Ann Intern Med 2008;149: 323-33. Annals of Internal Medicine
- Zöller B, Xinjun L, Sundquist J, Sundquist K. Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet 2011; : DOI:10.1016/S0140-6736(11)61306-8. DOI
- Trigg DE, Wood MG, Koides PA et al. Hormonal Influences on Haemostasis in Women. Sem Thromb Haemost 2011; 37: 77-86. PubMed
- Reid R, Leyland N, Wolfman W et al.Oral Contraceptives and the Risk of venous thromboembolism: An Update. J Obstet Gynaecol Can 2010; 32: 1192-7. PubMed
- Olie V, canonico M, Scarabin P-Y. Postmenopausal hormone therapy and venous thromboembolism. Thrombosis Res 2011 (E-Pub ahead of print).
- Canonico M, Plu-Bureau G, Lowe GDO, Scarabin P-Y. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis . BMJ 2008; 336: 1227-31. British Medical Journal
- Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ 2019; 364: k4810. doi:10.1136/bmj.k4810 DOI
- Bourjeily G, Paidas M, Khalil H, Rosene-Montella K, Rodger M. Pulmonary embolism in pregnancy. The Lancet 2009; 375: 500-12. The Lancet
- Deneux-Tharaux C, saucedo M, Bouvier-Colle MH. Pulmonary embolism in pregnancy. The Lancet 2010; 375: 1778-9. The Lancet
- Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-63. New England Journal of Medicine
- Gavish I, Brenner B. Air travel and the risk of thromboembolism. Intern Emerg Med 2010 Nov 6. Epub ahead of print.
- Watson HG and Baglin TP. Guidelines on travel-related venous thrombosis. BJH 2011; 152: 31-34. PubMed
- Hendriksen JMT, Geersin G-J, Lucassen WAM, et al. Diagnostic prediction models for suspected pulmonary embolism: systematic review and independent external validation in primary care. BMJ 2015; 351: h4438. doi:10.1136/bmj.h4438 DOI
- Shen J-H, Chen H-L, Chen J-R, et al. Comparison of the Wells score with the revised Geneva score for assessing suspected pulmonary embolism: a systematic review and meta-analysis. J Thromb Thrombolysis 2016; 41: 482-92. pmid:26178041 PubMed
- Righini M, Van Es J, Den Exter PL, et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA 2014; 311: 1117-24. pmid:24643601 PubMed
- Ceriani E, Combescure C, Le Gal G et al. Clinical prediction rules for pulmonary embolism: a systematic review and metaanalysis. J Thromb Haemost 2010; 8: 957-70. PubMed
- Gibson NS, Sohne M, Kruip MJ, et al. Further validation and simplification of the Wells clinical decision rule in pulmonary embolism. Thromb Haemost 2008; 99: 229-34. PubMed
- Lungemboli (LE). Janusinfo, Region Stockholm. Hämtad 2020-03-09 janusinfo.se
- Pesavento R, de Conti G, Minotto I, et al; for the TACEP study.The value of 64-detector row computed tomography for the exclusion of pulmonary embolism. Thromb Haemost. 2011; 105. 901-7. PMID: 21301781 PubMed
- Roncon L, Zuin M, Casazza F, et al. Impact of syncope and pre-syncope on short-term mortality in patients with acute pulmonary embolism. Eur J Intern 2018. pmid:29655808 PubMed
- Prandoni P, Lensing AWA, Prins MH et al. Prevalence of pulmonary embolism among patients hospitalized for syncope. N Engl J Med 2016; 375: 1524 – 31. pmid: 27797317 PubMed
- Moore AJE, Wachsmann J, Chamarthy MR, et al. Imaging of acute pulmonary embolism: an update. Cardiovasc Diagn Ther 2018; 8: 225-43. pmid:30057872 PubMed
- Bajc M, Schümichen C, Grüning T, et al. EANM guideline for ventilation/perfusion single-photon emission computed tomography (SPECT) for diagnosis of pulmonary embolism and beyond. Eur J Nucl Med Mol Imaging 2019. pmid:31410539 PubMed
- Shahir K, Goodman LR, Tali A, et al. Pulmonary embolism in pregnancy: CT pulmonary angiography versus perfusion scanning. Am J Roentgenol. 2010; 195 (3): W214-20. PMID: 20729418 PubMed
- Läkemedelsbehandling av venös trombos. Janusinfo Region Stockholm. Hämtad 2020-03-10 janusinfo.se
- Delluc A, Antic D, Lecumberri R, et al. Occult cancer screening in patients with venousthromboembolism: guidance from the SSC of the ISTH. J Thromb Haemost. 2017; 15: 2076-9. pmid:28851126 PubMed
- Wells PS, Forgie MA, Rodger MA. Treatment of venous thromboembolism. JAMA 2014; 311:717-28. doi: 10.1001/jama.2014.65 DOI
- Kearon C, Akl EA. Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism. Blood 2014; 123 (12): 1794-1801. doi: 10.1182/blood-2013-12-512681 DOI
- Lungemboli. Nationellt kliniskt kunskapsstöd. Hämtad 2022-07-15. nationelltklinisktkunskapsstod.se
- Segal JB, Streiff MB, Hofmann LV, Thornton K, Bass EB. Management of venous thromboembolism: a systematic review for a practice guideline. Ann Intern Med 2007; 146: 211-22. PubMed
- Blondon M, Bounemeaux H, Righini M et al.Treatment strategies for acute pulmonary embolism. Expert Opin Pharmacother 2009; 10: 1159-71. PubMed
- Colemen R and MacCallum P. Treatment and secondary prevention of venous thromboembolism in cancer. Br J C 2010; 102: Suppl 1: S17-23.
- Eichinger S and Kyrle PA. J. Duration of anticoagulation after initial idiopathic venous thrombosis – the swinging pendulum: Risk assessment to predict recurrence. Thromb Haemost 2009; 7: (suppl 1): 291-5.
- Shirley M, Dhillon S. Edoxaban: A Review in Deep Vein Thrombosis and Pulmonary Embolism. Drugs. 2015 Nov;75(17):2025-34. PMID:26546477. PubMed
- Benjamin D Fox, Susan R Kahn, David Langleben et al. Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials. BMJ. 2012; 345: e7498 PubMed
- Robertson L, Kesteven P, McCaslin JE. Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis. Cochrane Database Syst Rev. 2015 Jun 30;6:CD010956. doi: 10.1002/14651858.CD010956.pub2 DOI
- Själander S, Själander A. NOAK vid venös tromboembolism samt hantering av blödningar. Lakartidningen.se 2018-12-04. www.lakartidningen.se
- Dosering av lågmolekylärt heparin, fondaparinux och perorala antikoagulantia vid behandling av venös tromboembolism hos patienter med övervikt respektive undervikt, Janusinfo, region Stockholm, 2021-06-03 janusinfo.se
- Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d`Embolie Pulmonaire par Interruption Cave) randomized study. Circulation 2005; 112: 416-22. Circulation
- Bikdeli B, Wang Y, Jimenez D, et al. Association of Inferior Vena Cava Filter Use With Mortality Rates in Older Adults With Acute Pulmonary Embolism. JAMA Intern Med 2018. pmid:30535318 www.ncbi.nlm.nih.gov
- Geerts WH, Bergqvist D, Pineo GF et al. Prevention of Venous Thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: S381-S453.
- Huo MH and Spyropoulis AC. The eighth American college of chest phycisians guidelines on venous thromboembolism prevention: implications for hospital prophylaxis strategies. J Thromb Thrombolysis 2010 (e-pub ahead of print).
- Stanley A and Young A. Primary prevention of thromboembolism in medical and surgical oncology patients. BJC 2010; 102; S10-16.
- Carrier M, Le Gal G, Wells PS et al. Systematic review: case-fatality rates of recurrent Venous Thromboembolism and major Bleeding Events Among Patients treated for venous Thromboembolism. Ann Intern Med 2010; 152: 578-89. Annals of Internal Medicine
- Spyropoulus AC. To bridge or not to bridge: that’s the question. The argument FOR bridging therapy in patients on oral anticoagulants requiring temporary interruption for elective procedures. J Thromb Thrombolysis 2010; 29: 192-8. PubMed
- Amorosi SL, Tsilimingras K, Thompson D, Fanikos John, Weinstein MC, Goldhaber SZ. Cost analysis of "Bridging Therapy" with Low-Molecular-Weight Heparin versus Unfractionated Heparin during temporary interruption of chronic anticoagulation. A J Cardiol 2004; 93: 509-11. PubMed
- Klok FA and Huisman MV. Epidemiology and management of chronic thromboembolic pulmonary hypertension. Neth J Med 2010; 68: 347-351. PubMed
- Pollack CV, Reilly PA, van Ryn J, et al. Idarucizumab for dabigatran reversal - full cohort analysis. N Engl J Med 2017; 377: 431-441. PMID: 28693366 PubMed
- Rutherford O-CW, König MSS, Risnes K. Antidotbehandling ved bruk av direktevirkende antikoagulasjonsmidler. Tidsskr Nor Legeforen 2018. doi:10.4045/tidsskr.17.0190 DOI
- Niessner A, Tamargo J, Morais J et al. Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis. Eur Heart J 2017; 38: 1710 - 6. PMID: 26705385 PubMed
- Donzé J, Le Gal G, Fine MJ, et al. Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism. Thromb Haemost 2008; 100: 943-8. PubMed
- Yamashita Y, Morimoto T, Amano H, et al. Validation of simplified PESI score for identification of low-risk patients with pulmonary embolism: From the COMMAND VTE Registry published online ahead of print, 2018 Sep 11. Eur Heart J Acute Cardiovasc Care. 2018;2048872618799993. PMID: 30203659 PubMed
- Peter J Svensson, professor och överläkare, Koagulationscentrum, Skånes universitetssjukhus
- Anna Nager, med dr och specialist i allmänmedicin, Karolinska institutet